semaglutide hospitalizations is compound fda approved Compounded not the same as FDA-approved. The has documented dosing GLP-1 Receptor Agonists vs Alternatives

Individual outcomes differ

A 2024 analysis in The Lancet Diabetes & Endocrinology found that of the total weight lost on GLP-1 receptor agonists over 36-72 weeks, 25-39% represented lost muscle mass (rather than fat loss) [4]

Head-to-head comparative trials and studies of combination regimens are needed to establish optimal treatment sequencing and identify which patients benefit most from each approach or from their combination

It is not as effective as regular birth control if used repeatedly, so it is not recommended as a substitute for consistent contraception

Particles of any kind mean do not inject

Deakin JF, Slater P, Simpson MD, Gilchrist AC, Skan WJ, et al